|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 484.00 GBX | 0.00% |
|
-1.73% | -10.20% |
| Nov. 21 | HgCapital Trust gains from Intelerad sale to GE Healthcare | AN |
| Nov. 21 | HgCapital Trust agrees sale of Intelerad to GE HealthCare for $2.3 bln | RE |
| Capitalization | 2.22B 2.95B 2.54B 2.38B 4.09B 266B 4.45B 27.8B 10.73B 125B 11.08B 10.84B 459B | P/E ratio 2023 |
8.63x | P/E ratio 2024 | 10.4x |
|---|---|---|---|---|---|
| Enterprise value | 2.25B 3B 2.58B 2.42B 4.16B 270B 4.53B 28.29B 10.92B 128B 11.27B 11.03B 467B | EV / Sales 2023 |
6.69x | EV / Sales 2024 | 9.63x |
| Free-Float |
90.69% | Yield 2023 |
1.5% | Yield 2024 | 1.02% |
More valuation ratios
* Estimated data
More news
More recommendations
More press releases
More news
| 1 week | -1.73% | ||
| Current month | -1.73% | ||
| 1 month | +2.22% | ||
| 3 months | -2.81% | ||
| 6 months | -3.01% | ||
| Current year | -10.20% |
| 1 week | 478.5 |  | 493.5 |
| 1 month | 461.5 | | 493.5 |
| Current year | 420 | | 545 |
| 1 year | 420 | | 545 |
| 3 years | 317 | | 550 |
| 5 years | 295.5 | | 550 |
| 10 years | 98.1 | | 550 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 2009-12-31 | |
Matthew Barry
DFI | Director of Finance/CFO | - | 2012-07-31 |
David Toms
CTO | Chief Tech/Sci/R&D Officer | - | 2017-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Brooman
BRD | Director/Board Member | 70 | 2007-10-10 |
James Strang
CHM | Chairman | 54 | 2020-05-11 |
Pilar Junco
BRD | Director/Board Member | 49 | 2020-07-19 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -1.73% | -8.51% | +35.57% | 2.95B | |
| +0.61% | +0.42% | +10.67% | +37.08% | 15.59B | |
| +0.08% | -0.08% | +8.71% | +33.95% | 7.81B | |
| +0.22% | +1.98% | +35.23% | +141.68% | 6.94B | |
| +0.79% | -0.62% | -0.93% | +32.44% | 6.54B | |
| +0.35% | -0.70% | -4.04% | +31.19% | 4.29B | |
| +0.22% | +0.90% | +10.37% | +5.67% | 4.11B | |
| -0.57% | -0.57% | +19.45% | +27.32% | 3.49B | |
| +1.11% | -0.27% | +13.44% | +44.48% | 3.22B | |
| +1.73% | +1.29% | +41.40% | +57.72% | 3B | |
| Average | +0.45% | +0.06% | +12.58% | +44.71% | 5.79B | |
| Weighted average by Cap. | +0.45% | +0.21% | +12.22% | +46.81% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 256M 341M 293M 275M 473M 30.69B 514M 3.21B 1.24B 14.5B 1.28B 1.25B 53B | 260M 347M 298M 279M 481M 31.2B 523M 3.27B 1.26B 14.74B 1.3B 1.27B 53.88B |
| Net income | 231M 307M 264M 247M 426M 27.64B 463M 2.89B 1.12B 13.05B 1.15B 1.13B 47.73B | 236M 315M 270M 253M 436M 28.31B 474M 2.96B 1.14B 13.37B 1.18B 1.16B 48.89B |
| Net Debt | -275M -367M -315M -296M -509M -33.03B -553M -3.46B -1.33B -15.6B -1.38B -1.35B -57.03B | 39.1M 52.09M 44.78M 41.95M 72.21M 4.69B 78.55M 491M 189M 2.21B 196M 191M 8.1B |
More financial data
* Estimated data
Employees
-
Sector
Investment Trusts
Calendar
Mar. 09
- Q4 2025 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 484.00 p | 0.00% | 444,840 |
| 25-12-04 | 484.00 p | -0.41% | 526,192 |
| 25-12-03 | 486.00 p | +0.41% | 565,001 |
| 25-12-02 | 484.00 p | -0.82% | 314,637 |
| 25-12-01 | 488.00 p | -0.91% | 189,544 |
Delayed Quote London S.E., December 05, 2025 at 11:35 am EST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
4.840GBP
Average target price
5.400GBP
Spread / Average Target
+11.57%
Annual profits - Rate of surprise
- Stock Market
- Equities
- HGT Stock
Select your edition
All financial news and data tailored to specific country editions
